DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
He S, Shen J, Sun X, Liu L, Dong J.
A phase II FOLFOX-4 regimen as second-line treatment in advanced biliary tract cancer refractory to gemcitabine/cisplatin.
J Chemother 2014;
26: 243-7
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.